United States Pharmaceuticals

Pliant Therapeutics Inc (PLRX)

Track

Track

Pliant Therapeutics Inc. has seen no insider trading activity within the last three months. The most recent transactions occurred on January 20, 2026, involving planned sales by several executives, including the CEO, CFO, and COO. These divestments were part of established trading programs.
Ticker: PLRX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.5
Cummings Keith Lamont Chief Financial Officer Officer
Transaction date
Planned sale
Price
174.38
Quantity 22,797 -43.1%
Value US$3,721,495
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
137.33
Quantity 24,284 +42.6%
Value US$841,015
Kuo Minnie Chief Operating Officer Officer
Transaction date
Planned sale
Price
397.00
Quantity 89,572 -13.6%
Value US$2,560,053
Cheung Lily Chief Human Resource Officer Officer
Transaction date
Planned sale
Price
1.28
Quantity 7,534 -14.4%
Value US$9,644
0.5
MICHAEL OUIMETTE Officer Officer
Transaction date
Proposed sale
Price
11.07
Quantity 10,230
Value US$113,246
0.5
Ouimette Mike General Counsel & Corp. Sec'y Officer
Transaction date
Planned sale
Price
10.99
Quantity 10,230 -12.7%
Value US$112,462
0.5
Hull Hans Chief Business Officer Officer
Transaction date
Planned sale
Price
11.20
Quantity 15,936 -7.0%
Value US$178,501
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
11.20
Quantity 52,419 -10.9%
Value US$587,150
0.5
Cummings Keith Lamont Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.20
Quantity 20,148 -7.1%
Value US$225,680
0.5
Lefebvre Eric Chief Medical Officer Officer
Transaction date
Planned sale
Price
11.20
Quantity 18,478 -8.7%
Value US$206,974
0.5
Ouimette Mike General Counsel & Corp. Sec'y Officer
Transaction date
Planned sale
Price
11.20
Quantity 13,270 -14.1%
Value US$148,639
Cheung Lily Chief Human Resource Officer Officer
Transaction date
Planned sale
Price
11.20
Quantity 3,740 -13.2%
Value US$41,892
0.5
Ouimette Mike General Counsel & Corp. Sec'y Officer
Transaction date
Planned sale
Price
11.56
Quantity 7,656 -7.5%
Value US$88,503
0.5
Hull Hans Chief Business Officer Officer
Transaction date
Planned sale
Price
11.56
Quantity 9,900 -4.2%
Value US$114,444
0.5
Cummings Keith Lamont Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.56
Quantity 10,911 -3.7%
Value US$126,131
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
11.56
Quantity 38,710 -7.4%
Value US$447,488
0.5
Lefebvre Eric Chief Medical Officer Officer
Transaction date
Planned sale
Price
11.56
Quantity 12,319 -5.5%
Value US$142,408
0.5
Ouimette Mike General Counsel & Corp. Sec'y Officer
Transaction date
Planned sale
Price
17.23
Quantity 5,197 -8.6%
Value US$89,544
0.5
Hull Hans Chief Business Officer Officer
Transaction date
Planned sale
Price
17.23
Quantity 9,786 -5.0%
Value US$168,613
0.5
Lefebvre Eric Chief Medical Officer Officer
Transaction date
Planned sale
Price
17.23
Quantity 10,295 -6.2%
Value US$177,383
0.5
Cummings Keith Lamont Chief Financial Officer Officer
Transaction date
Planned sale
Price
17.23
Quantity 9,781 -4.8%
Value US$168,527
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
17.23
Quantity 25,721 -7.5%
Value US$443,173
0.5
Hull Hans Chief Business Officer Officer
Transaction date
Planned sale
Price
20.01
Quantity 20,050 -9.3%
Value US$401,200
0.5
Hull Hans Chief Business Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 13,069 -6.0%
Value US$261,380
0.5
JOHANNES P HULL Officer Officer
Transaction date
Proposed sale
Price
18.90
Quantity 34,919
Value US$659,969
0.5
Ouimette Mike General Counsel & Corp. Sec'y Officer
Transaction date
Planned sale
Price
17.55
Quantity 4,755 -7.3%
Value US$83,450
0.5
MICHAEL OUIMETTE Officer Officer
Transaction date
Proposed sale
Price
17.82
Quantity 4,755
Value US$84,734
0.5
Ouimette Mike General Counsel & Corp. Sec'y Officer
Transaction date
Planned sale
Price
18.01
Quantity 12,778 -16.4%
Value US$230,120
0.5
Lefebvre Eric Chief Medical Officer Officer
Transaction date
Planned sale
Price
18.01
Quantity 22,321 -11.8%
Value US$401,981
0.5
Cummings Keith Lamont Chief Financial Officer Officer
Transaction date
Planned sale
Price
18.01
Quantity 19,771 -8.8%
Value US$356,058
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
18.01
Quantity 70,150 -17.0%
Value US$1,263,338
0.5
Hull Hans Chief Business Officer Officer
Transaction date
Planned sale
Price
18.01
Quantity 17,937 -7.6%
Value US$323,029
0.5
Ouimette Mike General Counsel & Corp. Sec'y Officer
Transaction date
Planned sale
Price
27.46
Quantity 200 -0.4%
Value US$5,491
0.5
Ouimette Mike General Counsel & Corp. Sec'y Officer
Transaction date
Planned sale
Price
26.74
Quantity 2,677 -5.0%
Value US$71,575
0.5
Cummings Keith Lamont Chief Financial Officer Officer
Transaction date
Planned sale
Price
26.52
Quantity 9,960 -6.3%
Value US$264,148
0.5
Lefebvre Eric Chief Medical Officer Officer
Transaction date
Planned sale
Price
26.52
Quantity 11,245 -7.2%
Value US$298,228
0.5
Hull Hans Chief Business Officer Officer
Transaction date
Planned sale
Price
26.52
Quantity 9,036 -4.3%
Value US$239,643
0.5
Ouimette Mike General Counsel & Corp. Sec'y Officer
Transaction date
Planned sale
Price
26.52
Quantity 4,874 -8.3%
Value US$129,263
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
26.52
Quantity 35,339 -11.4%
Value US$937,222
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
34.08
Quantity 5,262 -2.1%
Value US$179,312
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
33.36
Quantity 9,738 -3.8%
Value US$324,888
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
34.96
Quantity 1,605 -0.7%
Value US$56,105
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
34.13
Quantity 13,395 -5.3%
Value US$457,124
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
35.55
Quantity 105 -0.0%
Value US$3,733
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
34.78
Quantity 5,440 -2.2%
Value US$189,192
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
34.15
Quantity 9,455 -3.7%
Value US$322,841
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
34.92
Quantity 15,000 -5.9%
Value US$523,755
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
34.66
Quantity 3,605 -1.5%
Value US$124,938
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
33.98
Quantity 11,395 -4.5%
Value US$387,177
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
36.64
Quantity 221 -0.1%
Value US$8,097
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
35.09
Quantity 9,779 -2.3%
Value US$343,158
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
36.06
Quantity 6,302 -2.6%
Value US$227,243
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
35.42
Quantity 8,698 -3.4%
Value US$308,046
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
35.10
Quantity 15,000 -3.5%
Value US$526,425
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
35.29
Quantity 15,000 -5.9%
Value US$529,366
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
33.29
Quantity 1,696 -1.8%
Value US$56,459
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
32.40
Quantity 13,304 -12.2%
Value US$431,058
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
30.89
Quantity 15,000 -13.8%
Value US$463,389
0.5
Cummings Keith Lamont Chief Financial Officer Officer
Transaction date
Planned sale
Price
35.00
Quantity 30,000 -26.2%
Value US$1,050,000
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
35.00
Quantity 15,000 -3.3%
Value US$525,000
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
34.93
Quantity 4,850 -4.9%
Value US$169,405
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
33.71
Quantity 10,150 -9.3%
Value US$342,163
0.5
Ouimette Mike General Counsel & Corp. Sec'y Officer
Transaction date
Planned sale
Price
34.19
Quantity 20,000 -77.1%
Value US$683,878
0.5
Lefebvre Eric Chief Medical Officer Officer
Transaction date
Planned sale
Price
34.48
Quantity 67,500 -46.7%
Value US$2,327,630
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
19.17
Quantity 5,000 -5.1%
Value US$95,829
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
19.04
Quantity 15,000 -13.8%
Value US$285,584
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
19.06
Quantity 15,000 -13.8%
Value US$285,940
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Planned sale
Price
19.33
Quantity 15,000 -13.8%
Value US$289,952
0.5
Ouimette Mike General Counsel & Corp. Sec'y Officer
Transaction date
Planned sale
Price
19.38
Quantity 2,928 -33.0%
Value US$56,731
0.5
Coulie Bernard President and CEO Executive Director
Transaction date
Sale
Price
19.10
Quantity 34,212 -26.7%
Value US$653,531
0.5
Hull Hans Chief Business Officer Officer
Transaction date
Sale
Price
19.10
Quantity 8,748 -6.0%
Value US$167,108
0.5
Ouimette Mike General Counsel & Corp. Sec'y Officer
Transaction date
Sale
Price
19.10
Quantity 4,719 -34.7%
Value US$90,144
0.5
Lefebvre Eric Chief Medical Officer Officer
Transaction date
Sale
Price
19.10
Quantity 10,887 -7.0%
Value US$207,968
0.5
Cummings Keith Lamont Chief Financial Officer Officer
Transaction date
Sale
Price
19.10
Quantity 9,643 -10.7%
Value US$184,204
0.5
Lefebvre Eric Chief Medical Officer Officer
Transaction date
Planned sale
Price
25.05
Quantity 5,000 -3.6%
Value US$125,241
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-22 2026-01-20 PlS Planned sale
0.5
Cummings Keith Lamont

Chief Financial Officer

Officer
22,797 -43.1%
174.38
US$3,721,495 		22,797 -43.1% 174.38 US$3,721,495
2026-01-22 2026-01-20 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
24,284 +42.6%
137.33
US$841,015 		24,284 +42.6% 137.33 US$841,015
2026-01-22 2026-01-20 PlS Planned sale
Kuo Minnie

Chief Operating Officer

Officer
89,572 -13.6%
397.00
US$2,560,053 		89,572 -13.6% 397.00 US$2,560,053
2026-01-22 2026-01-20 PlS Planned sale
Cheung Lily

Chief Human Resource Officer

Officer
7,534 -14.4%
1.28
US$9,644 		7,534 -14.4% 1.28 US$9,644
2025-01-22 2025-01-22 PrS Proposed sale
0.5
MICHAEL OUIMETTE

Officer

Officer
10,230
11.07
US$113,246 		10,230 11.07 US$113,246
2025-01-22 2025-01-22 PlS Planned sale
0.5
Ouimette Mike

General Counsel & Corp. Sec'y

Officer
10,230 -12.7%
10.99
US$112,462 		10,230 -12.7% 10.99 US$112,462
2025-01-22 2025-01-17 PlS Planned sale
0.5
Hull Hans

Chief Business Officer

Officer
15,936 -7.0%
11.20
US$178,501 		15,936 -7.0% 11.20 US$178,501
2025-01-22 2025-01-17 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
52,419 -10.9%
11.20
US$587,150 		52,419 -10.9% 11.20 US$587,150
2025-01-22 2025-01-17 PlS Planned sale
0.5
Cummings Keith Lamont

Chief Financial Officer

Officer
20,148 -7.1%
11.20
US$225,680 		20,148 -7.1% 11.20 US$225,680
2025-01-22 2025-01-17 PlS Planned sale
0.5
Lefebvre Eric

Chief Medical Officer

Officer
18,478 -8.7%
11.20
US$206,974 		18,478 -8.7% 11.20 US$206,974
2025-01-22 2025-01-17 PlS Planned sale
0.5
Ouimette Mike

General Counsel & Corp. Sec'y

Officer
13,270 -14.1%
11.20
US$148,639 		13,270 -14.1% 11.20 US$148,639
2025-01-22 2025-01-17 PlS Planned sale
Cheung Lily

Chief Human Resource Officer

Officer
3,740 -13.2%
11.20
US$41,892 		3,740 -13.2% 11.20 US$41,892
2024-07-12 2024-07-10 PlS Planned sale
0.5
Ouimette Mike

General Counsel & Corp. Sec'y

Officer
7,656 -7.5%
11.56
US$88,503 		7,656 -7.5% 11.56 US$88,503
2024-07-12 2024-07-10 PlS Planned sale
0.5
Hull Hans

Chief Business Officer

Officer
9,900 -4.2%
11.56
US$114,444 		9,900 -4.2% 11.56 US$114,444
2024-07-12 2024-07-10 PlS Planned sale
0.5
Cummings Keith Lamont

Chief Financial Officer

Officer
10,911 -3.7%
11.56
US$126,131 		10,911 -3.7% 11.56 US$126,131
2024-07-12 2024-07-10 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
38,710 -7.4%
11.56
US$447,488 		38,710 -7.4% 11.56 US$447,488
2024-07-12 2024-07-10 PlS Planned sale
0.5
Lefebvre Eric

Chief Medical Officer

Officer
12,319 -5.5%
11.56
US$142,408 		12,319 -5.5% 11.56 US$142,408
2024-01-19 2024-01-17 PlS Planned sale
0.5
Ouimette Mike

General Counsel & Corp. Sec'y

Officer
5,197 -8.6%
17.23
US$89,544 		5,197 -8.6% 17.23 US$89,544
2024-01-19 2024-01-17 PlS Planned sale
0.5
Hull Hans

Chief Business Officer

Officer
9,786 -5.0%
17.23
US$168,613 		9,786 -5.0% 17.23 US$168,613
2024-01-19 2024-01-17 PlS Planned sale
0.5
Lefebvre Eric

Chief Medical Officer

Officer
10,295 -6.2%
17.23
US$177,383 		10,295 -6.2% 17.23 US$177,383
2024-01-19 2024-01-17 PlS Planned sale
0.5
Cummings Keith Lamont

Chief Financial Officer

Officer
9,781 -4.8%
17.23
US$168,527 		9,781 -4.8% 17.23 US$168,527
2024-01-19 2024-01-17 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
25,721 -7.5%
17.23
US$443,173 		25,721 -7.5% 17.23 US$443,173
2023-08-07 2023-08-04 PlS Planned sale
0.5
Hull Hans

Chief Business Officer

Officer
20,050 -9.3%
20.01
US$401,200 		20,050 -9.3% 20.01 US$401,200
2023-08-07 2023-08-03 PlS Planned sale
0.5
Hull Hans

Chief Business Officer

Officer
13,069 -6.0%
20.00
US$261,380 		13,069 -6.0% 20.00 US$261,380
2023-08-03 2023-08-03 PrS Proposed sale
0.5
JOHANNES P HULL

Officer

Officer
34,919
18.90
US$659,969 		34,919 18.90 US$659,969
2023-07-21 2023-07-20 PlS Planned sale
0.5
Ouimette Mike

General Counsel & Corp. Sec'y

Officer
4,755 -7.3%
17.55
US$83,450 		4,755 -7.3% 17.55 US$83,450
2023-07-20 2023-07-20 PrS Proposed sale
0.5
MICHAEL OUIMETTE

Officer

Officer
4,755
17.82
US$84,734 		4,755 17.82 US$84,734
2023-07-19 2023-07-17 PlS Planned sale
0.5
Ouimette Mike

General Counsel & Corp. Sec'y

Officer
12,778 -16.4%
18.01
US$230,120 		12,778 -16.4% 18.01 US$230,120
2023-07-19 2023-07-17 PlS Planned sale
0.5
Lefebvre Eric

Chief Medical Officer

Officer
22,321 -11.8%
18.01
US$401,981 		22,321 -11.8% 18.01 US$401,981
2023-07-19 2023-07-17 PlS Planned sale
0.5
Cummings Keith Lamont

Chief Financial Officer

Officer
19,771 -8.8%
18.01
US$356,058 		19,771 -8.8% 18.01 US$356,058
2023-07-19 2023-07-17 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
70,150 -17.0%
18.01
US$1,263,338 		70,150 -17.0% 18.01 US$1,263,338
2023-07-19 2023-07-17 PlS Planned sale
0.5
Hull Hans

Chief Business Officer

Officer
17,937 -7.6%
18.01
US$323,029 		17,937 -7.6% 18.01 US$323,029
2023-04-03 2023-04-03 PlS Planned sale
0.5
Ouimette Mike

General Counsel & Corp. Sec'y

Officer
200 -0.4%
27.46
US$5,491 		200 -0.4% 27.46 US$5,491
2023-04-03 2023-04-03 PlS Planned sale
0.5
Ouimette Mike

General Counsel & Corp. Sec'y

Officer
2,677 -5.0%
26.74
US$71,575 		2,677 -5.0% 26.74 US$71,575
2023-04-03 2023-03-30 PlS Planned sale
0.5
Cummings Keith Lamont

Chief Financial Officer

Officer
9,960 -6.3%
26.52
US$264,148 		9,960 -6.3% 26.52 US$264,148
2023-04-03 2023-03-30 PlS Planned sale
0.5
Lefebvre Eric

Chief Medical Officer

Officer
11,245 -7.2%
26.52
US$298,228 		11,245 -7.2% 26.52 US$298,228
2023-04-03 2023-03-30 PlS Planned sale
0.5
Hull Hans

Chief Business Officer

Officer
9,036 -4.3%
26.52
US$239,643 		9,036 -4.3% 26.52 US$239,643
2023-04-03 2023-03-30 PlS Planned sale
0.5
Ouimette Mike

General Counsel & Corp. Sec'y

Officer
4,874 -8.3%
26.52
US$129,263 		4,874 -8.3% 26.52 US$129,263
2023-04-03 2023-03-30 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
35,339 -11.4%
26.52
US$937,222 		35,339 -11.4% 26.52 US$937,222
2023-02-06 2023-02-03 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
5,262 -2.1%
34.08
US$179,312 		5,262 -2.1% 34.08 US$179,312
2023-02-06 2023-02-03 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
9,738 -3.8%
33.36
US$324,888 		9,738 -3.8% 33.36 US$324,888
2023-02-06 2023-02-02 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
1,605 -0.7%
34.96
US$56,105 		1,605 -0.7% 34.96 US$56,105
2023-02-06 2023-02-02 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
13,395 -5.3%
34.13
US$457,124 		13,395 -5.3% 34.13 US$457,124
2023-02-01 2023-02-01 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
105 -0.0%
35.55
US$3,733 		105 -0.0% 35.55 US$3,733
2023-02-01 2023-02-01 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
5,440 -2.2%
34.78
US$189,192 		5,440 -2.2% 34.78 US$189,192
2023-02-01 2023-02-01 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
9,455 -3.7%
34.15
US$322,841 		9,455 -3.7% 34.15 US$322,841
2023-02-01 2023-01-31 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
15,000 -5.9%
34.92
US$523,755 		15,000 -5.9% 34.92 US$523,755
2023-02-01 2023-01-30 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
3,605 -1.5%
34.66
US$124,938 		3,605 -1.5% 34.66 US$124,938
2023-02-01 2023-01-30 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
11,395 -4.5%
33.98
US$387,177 		11,395 -4.5% 33.98 US$387,177
2023-01-27 2023-01-27 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
221 -0.1%
36.64
US$8,097 		221 -0.1% 36.64 US$8,097
2023-01-27 2023-01-27 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
9,779 -2.3%
35.09
US$343,158 		9,779 -2.3% 35.09 US$343,158
2023-01-27 2023-01-27 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
6,302 -2.6%
36.06
US$227,243 		6,302 -2.6% 36.06 US$227,243
2023-01-27 2023-01-27 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
8,698 -3.4%
35.42
US$308,046 		8,698 -3.4% 35.42 US$308,046
2023-01-27 2023-01-26 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
15,000 -3.5%
35.10
US$526,425 		15,000 -3.5% 35.10 US$526,425
2023-01-27 2023-01-26 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
15,000 -5.9%
35.29
US$529,366 		15,000 -5.9% 35.29 US$529,366
2023-01-25 2023-01-25 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
1,696 -1.8%
33.29
US$56,459 		1,696 -1.8% 33.29 US$56,459
2023-01-25 2023-01-25 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
13,304 -12.2%
32.40
US$431,058 		13,304 -12.2% 32.40 US$431,058
2023-01-25 2023-01-24 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
15,000 -13.8%
30.89
US$463,389 		15,000 -13.8% 30.89 US$463,389
2023-01-25 2023-01-23 PlS Planned sale
0.5
Cummings Keith Lamont

Chief Financial Officer

Officer
30,000 -26.2%
35.00
US$1,050,000 		30,000 -26.2% 35.00 US$1,050,000
2023-01-25 2023-01-23 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
15,000 -3.3%
35.00
US$525,000 		15,000 -3.3% 35.00 US$525,000
2023-01-25 2023-01-23 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
4,850 -4.9%
34.93
US$169,405 		4,850 -4.9% 34.93 US$169,405
2023-01-25 2023-01-23 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
10,150 -9.3%
33.71
US$342,163 		10,150 -9.3% 33.71 US$342,163
2023-01-25 2023-01-23 PlS Planned sale
0.5
Ouimette Mike

General Counsel & Corp. Sec'y

Officer
20,000 -77.1%
34.19
US$683,878 		20,000 -77.1% 34.19 US$683,878
2023-01-25 2023-01-23 PlS Planned sale
0.5
Lefebvre Eric

Chief Medical Officer

Officer
67,500 -46.7%
34.48
US$2,327,630 		67,500 -46.7% 34.48 US$2,327,630
2023-01-09 2023-01-09 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
5,000 -5.1%
19.17
US$95,829 		5,000 -5.1% 19.17 US$95,829
2023-01-09 2023-01-06 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
15,000 -13.8%
19.04
US$285,584 		15,000 -13.8% 19.04 US$285,584
2023-01-05 2023-01-04 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
15,000 -13.8%
19.06
US$285,940 		15,000 -13.8% 19.06 US$285,940
2023-01-05 2023-01-03 PlS Planned sale
0.5
Coulie Bernard

President and CEO

Executive Director
15,000 -13.8%
19.33
US$289,952 		15,000 -13.8% 19.33 US$289,952
2022-12-23 2022-12-22 PlS Planned sale
0.5
Ouimette Mike

General Counsel & Corp. Sec'y

Officer
2,928 -33.0%
19.38
US$56,731 		2,928 -33.0% 19.38 US$56,731
2022-12-21 2022-12-20 S Sale
0.5
Coulie Bernard

President and CEO

Executive Director
34,212 -26.7%
19.10
US$653,531 		34,212 -26.7% 19.10 US$653,531
2022-12-21 2022-12-20 S Sale
0.5
Hull Hans

Chief Business Officer

Officer
8,748 -6.0%
19.10
US$167,108 		8,748 -6.0% 19.10 US$167,108
2022-12-21 2022-12-20 S Sale
0.5
Ouimette Mike

General Counsel & Corp. Sec'y

Officer
4,719 -34.7%
19.10
US$90,144 		4,719 -34.7% 19.10 US$90,144
2022-12-21 2022-12-20 S Sale
0.5
Lefebvre Eric

Chief Medical Officer

Officer
10,887 -7.0%
19.10
US$207,968 		10,887 -7.0% 19.10 US$207,968
2022-12-21 2022-12-20 S Sale
0.5
Cummings Keith Lamont

Chief Financial Officer

Officer
9,643 -10.7%
19.10
US$184,204 		9,643 -10.7% 19.10 US$184,204
2022-10-27 2022-10-25 PlS Planned sale
0.5
Lefebvre Eric

Chief Medical Officer

Officer
5,000 -3.6%
25.05
US$125,241 		5,000 -3.6% 25.05 US$125,241
Explore more

More insider trading research around Pliant Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America